1. Home
  2. IRIX vs GNTA Comparison

IRIX vs GNTA Comparison

Compare IRIX & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

HOLD

Current Price

$0.99

Market Cap

23.2M

Sector

Health Care

ML Signal

HOLD

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$0.65

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRIX
GNTA
Founded
1989
2014
Country
United States
Italy
Employees
N/A
13
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.2M
19.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
IRIX
GNTA
Price
$0.99
$0.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
48.7K
63.3K
Earning Date
03-26-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
8.47
N/A
EPS
N/A
N/A
Revenue
$41,593,000.00
N/A
Revenue This Year
$10.43
N/A
Revenue Next Year
$7.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.79
$0.59
52 Week High
$1.65
$10.00

Technical Indicators

Market Signals
Indicator
IRIX
GNTA
Relative Strength Index (RSI) 23.19 36.26
Support Level $0.87 $0.59
Resistance Level $1.22 $1.70
Average True Range (ATR) 0.07 0.11
MACD -0.03 0.00
Stochastic Oscillator 8.43 16.67

Price Performance

Historical Comparison
IRIX
GNTA

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: